Vimarsana
Biggest News Aggregation in the World

Page 8 - Drug Controller General News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Drug Controller General. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Drug Controller General Today - Breaking & Trending Today

bdr pharmaceuticals: BDR Pharmaceuticals introduces prostate cancer treatment drug in oral solution form - Vimarsana News

bdr pharmaceuticals: BDR Pharmaceuticals introduces prostate cancer treatment drug in oral solution form

It is a more patient-friendly way to tackle prostate cancer. It can help improve patient compliance to a great extent, Badiger said. The company said introducing the Drug Controller General of India (DCGI)approved new drug delivery system will make it more affordable and accessible in India.

Newsmaker | 'Upgrade Quality or Risk Shutdowns': How India's New DCGI is Rebuilding 'Pharmacy of the World' - Vimarsana News

Newsmaker | 'Upgrade Quality or Risk Shutdowns': How India's New DCGI is Rebuilding 'Pharmacy of the World'

In February, India appointed Raghuvanshi, the first DCGI from the corporate world who boasted of stints at Ranbaxy and Dr. Reddy’s among others

Source: news18.com
India's pharma lobby bats for drug approvals in line with global markets - Vimarsana News

India's pharma lobby bats for drug approvals in line with global markets

According to the OPPI, launching a new drug in India is delayed by up to four years, compared to markets like the US and the European Union. This affects the launch of innovative and significant products in India. The lobby represents pharma giants including Novartis, Roche, AstraZeneca, Sanofi and Merck. The group blames the delay on complex clinical trial regulations.

Uttarakhand Drug Regulator Enforces Ban on Cough Syrup Production Without Testing for Toxic Chemicals - Vimarsana News

Uttarakhand Drug Regulator Enforces Ban on Cough Syrup Production Without Testing for Toxic Chemicals

In a move to uphold the manufacturing standards of cough syrups, the health regulator of Uttarakhand has decided to ban the production of syrups by drug makers who cannot conduct sample testing through gas chromatography, News18 has learnt.

Source: news18.com
Serum Institute eyes approval for XBB1 variant vaccine to tackle COVID-19 JN.1 strain - Vimarsana News

Serum Institute eyes approval for XBB1 variant vaccine to tackle COVID-19 JN.1 strain

India reported 1,394 active cases of Covid-19 on December22, 5 am, according to the data provided by the Ministry of Health and Family Welfare